Stay updated on Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Footer shows a minor version update from Revision: v3.4.1 to v3.4.2. No study content or essential page functionality appears affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:29:17.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. No substantive changes to study information or site functionality are evident.
    Difference
    0.0%
    Check dated 2026-02-05T23:48:09.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The 'Last Update Posted (Estimated)' label was replaced with a new 'Last Update Posted' label, removing the estimated qualifier. This is a minor UI change that does not affect the study data or its interpretation, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-22T09:31:19.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The study now indicates transition to a long-term extension phase (LTEP) with Part E closed to enrollment; Part D and Part F closed, and Part G enrolling only for HNSCC with its cohort not opened. Part A dosing is now listed as every 3 weeks, and Part D dosing on Day 1 of each 21-day cycle; the page reports 172 locations.
    Difference
    0.5%
    Check dated 2026-01-15T04:52:44.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a comprehensive list of trial locations across multiple states and countries, and removed several locations from the list.
    Difference
    2%
    Check dated 2025-12-23T22:00:56.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The study locations list has been expanded to 174 sites across the United States and internationally, including UC San Diego, Yale-New Haven, Massachusetts General Hospital, OHSU, and Ophthalmic Consultants of Boston. The total number of locations shown is now 174.
    Difference
    0.8%
    Check dated 2025-12-09T19:02:45.000Z thumbnail image

Stay in the know with updates to Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.